4.5 Article

β2-Adrenoceptor agonists in the regulation of mitochondrial biogenesis

Journal

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Volume 23, Issue 19, Pages 5376-5381

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2013.07.052

Keywords

Adrenoceptor; Biogenesis; Mitochondria; Pharmacophore; Chemical similarity; Clustering; Renal

Funding

  1. National Institutes of Health [T32 CA119945-04, F32 ES020103-01, ES012878, DK071997, GM084147]
  2. Biomedical LaboratoryResearch and Development Program of the Department of Veterans Affairs [1BX000851]
  3. [T32 GM08716]

Ask authors/readers for more resources

The stimulation of mitochondrial biogenesis (MB) via cell surface G-protein coupled receptors is a promising strategy for cell repair and regeneration. Here we report the specificity and chemical rationale of a panel of beta(2)-adrenoceptor agonists with regards to MB. Using primary cultures of renal cells, a diverse panel of beta(2)-adrenoceptor agonists elicited three distinct phenotypes: full MB, partial MB, and non-MB. Full MB compounds had efficacy in the low nanomolar range and represent two chemical scaffolds containing three distinct chemical clusters. Interestingly, the MB phenotype did not correlate with reported receptor affinity or chemical similarity. Chemical clusters were then subjected to pharmacophore modeling creating two models with unique and distinct features, consisting of five conserved amongst full MB compounds were identified. The two discrete pharmacophore models were coalesced into a consensus pharmacophore with four unique features elucidating the spatial and chemical characteristics required to stimulate MB. (C) 2013 The Authors. Published by Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available